[Form 4] DocuSign, Inc. Insider Trading Activity
Michael G. Rosenbaum, a director of DocuSign, Inc. (DOCU), was granted 6,265 restricted stock units (RSUs) on 09/09/2025. Each RSU converts to one share of common stock upon vesting and was issued at no cash price. The RSUs vest in twelve equal quarterly installments over three years, with a vesting commencement date of 09/03/2025, provided the reporting person remains a service provider through each vesting date. The RSUs do not expire; they either vest or are canceled prior to vesting. The Form 4 was signed by an attorney-in-fact on 09/10/2025.
- Service-based equity grant aligns director incentives with shareholders through multi-year vesting
- No cash price paid for the RSUs, indicating standard compensation rather than a purchase
- None.
Insights
TL;DR Director received a standard equity grant of 6,265 RSUs that vests quarterly over three years, aligning pay with ongoing service.
The grant appears to be routine director compensation rather than a transaction indicating material ownership change. The RSU structure—twelve equal quarterly installments over three years with a September 3, 2025 commencement—ties value realization to continued service, supporting director alignment with shareholder interests. No exercise price or cash consideration was paid, and the RSUs are contingent on service through each vesting date. For investors this is immaterial to company valuation given the modest size relative to typical market-capitalization for a public company.
TL;DR The award is a non-expiring RSU grant with pro-rata quarterly vesting, consistent with standard long-term incentive design.
The grant’s mechanics—one RSU per share upon vesting, no expiration, and quarterly vesting over three years—are consistent with common corporate governance practices for director retention and alignment. The absence of a purchase price and the description that RSUs either vest or are canceled prior to vesting confirm these are service-based awards. The transaction code indicates an acquisition of derivative securities. There is no indication of accelerated vesting triggers or transfer to related parties in this filing.